MDT Earnings Explosion – 95C Call for Big Gains!
# 💉 MDT Earnings Call Option – 95C Play (8/21 BMO)
📊 **Market Snapshot**
* Revenue Growth: +3.9% TTM
* Margins: Profit 13.9%, Operating 17.1%, Gross 65.4%
* Earnings Beat History: 100% past 8 quarters ✅
* Forward EPS: \$5.85 → ambitious 62% growth expectation
* Technical Support/Resistance: \$92
Key facts today
Medtronic's Minimed™ 780G system has gained FDA approval, now integrating with Abbott's Instinct sensor for type 2 diabetes patients, with compliance expected soon.
0.70 USD
3.94 B USD
28.37 B USD
About Medtronic plc.
Sector
Industry
CEO
Geoffrey Straub Martha
Website
Headquarters
Galway
Founded
2014
ISIN
ARDEUT111283
FIGI
BBG000HFXTS7
Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment includes products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Neuroscience Portfolio is made up of cranial and spinal technologies, specialty therapies, and neuromodulation divisions. The Medical Surgical Portfolio is comprised of surgical innovations and respiratory, gastrointestinal, and renal divisions. The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Related stocks
Chartamentals (Charting + Fundamentals) : #MDTPrice-to-Earnings (P/E): 16.33; Trailing P/E is moderate, below medical device industry average (20–25).
Price-to-Operating Cash Flow: ~10–12 (estimated); Not explicitly provided, reasonable for strong cash flow generation.
Strategic Advantage: Global leader in heart devices, spinal products, insuli
Medtronic Stock Chart Fibonacci Analysis 042925Trading Idea
1) Find a FIBO slingshot
2) Check FIBO 61.80% level
3) Entry Point > 83.2/61.80%
Chart time frame:B
A) 15 min(1W-3M)
B) 1 hr(3M-6M)
C) 4 hr(6M-1year)
D) 1 day(1-3years)
Stock progress: A
A) Keep rising over 61.80% resistance
B) 61.80% resistance
C) 61.80% support
D) Hit the bottom
MedTronic - What is your Opinion? Shall we discuss it?This time as an experiment, why don't we discuss the prospects before taking action-
HERE IS MY CONTRIBUTION - can we all collaborate ?
What Medtronic is doing right:
It looks like these guys make transplant patients nervouse, nervous to have their pace makers hacked. That has t increase liability
Medtronic breaking outNYSE:MDT is breaking out of this multi year base.
* The current weekly close is super strong (if it closes like this)
* no MA resistance on the daily (above 50,100 & 200)
* Above 50 & 100 MAs on Weekly
* IHS breakout on the weekly chart, followed by a flag and retest of support zone
I am currently
Medtronic plc.
The price is currently hovering near the upper band, which suggests the stock may be experiencing some upward momentum.
Support: Around $87, where the price found buyers recently after a pullback.
Resistance: Immediate resistance is near $91.50, which is the high from a recent candle.
The middl
MDT Medtronic plc Options Ahead of EarningsIf you haven`t bought the dip on MDT:
Now analyzing the options chain and the chart patterns of MDT Medtronic plc prior to the earnings report this week,
I would consider purchasing the 85usd strike price Calls with
an expiration date of 2024-8-23,
for a premium of approximately $1.32.
If these op
See all ideas
Displays a symbol's price movements over previous years to identify recurring trends.
MDT.GO
Medtronic, Inc. 5.55% 15-MAR-2040Yield to maturity
—
Maturity date
Mar 15, 2040
MDT4284341
Medtronic, Inc. 4.375% 15-MAR-2035Yield to maturity
—
Maturity date
Mar 15, 2035
MDT4284342
Medtronic, Inc. 4.625% 15-MAR-2045Yield to maturity
—
Maturity date
Mar 15, 2045
MDT4099940
Medtronic, Inc. 4.625% 15-MAR-2044Yield to maturity
—
Maturity date
Mar 15, 2044
MDT.GM
Medtronic, Inc. 6.5% 15-MAR-2039Yield to maturity
—
Maturity date
Mar 15, 2039
MDT3673737
Covidien International Finance SA 6.55% 15-OCT-2037Yield to maturity
—
Maturity date
Oct 15, 2037
MDT5559728
Medtronic Global Holdings S.C.A. 4.25% 30-MAR-2028Yield to maturity
—
Maturity date
Mar 30, 2028
MDT5559704
Medtronic Global Holdings S.C.A. 4.5% 30-MAR-2033Yield to maturity
—
Maturity date
Mar 30, 2033
MDT3831466
Medtronic, Inc. 4.5% 15-MAR-2042Yield to maturity
—
Maturity date
Mar 15, 2042
XS196067868
Medtronic Global Holdings S.C.A. 2.25% 07-MAR-2039Yield to maturity
—
Maturity date
Mar 7, 2039
XS223879217
Medtronic Global Holdings S.C.A. 0.75% 15-OCT-2032Yield to maturity
—
Maturity date
Oct 15, 2032
See all MDTC bonds